These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Intracranial metastases of cancer of the prostate]. Demierre B; Berney J Neurochirurgie; 1983; 29(2):143-9. PubMed ID: 6888633 [TBL] [Abstract][Full Text] [Related]
23. Hypocalcemia due to avid calcium uptake by osteoblastic metastases of prostate cancer. Szentirmai M; Constantinou C; Rainey JM; Loewenstein JE West J Med; 1995 Dec; 163(6):577-8. PubMed ID: 8553652 [No Abstract] [Full Text] [Related]
24. [A case of prostatic small cell carcinoma]. Hashimoto Y; Kimura G; Tsuboi N; Akimoto M Hinyokika Kiyo; 2000 Jun; 46(6):425-7. PubMed ID: 10934615 [TBL] [Abstract][Full Text] [Related]
25. Intracranial metastatic adenocarcinoma of the prostate presenting as visual disturbance. Preston DM; Zeidman SM; Spevak M; Moul JW; Costabile RA Tech Urol; 1997; 3(1):51-3. PubMed ID: 9170227 [TBL] [Abstract][Full Text] [Related]
27. Role of Wnts in prostate cancer bone metastases. Hall CL; Kang S; MacDougald OA; Keller ET J Cell Biochem; 2006 Mar; 97(4):661-72. PubMed ID: 16447163 [TBL] [Abstract][Full Text] [Related]
28. Parathyroid hormone-related peptide: expression in prostate cancer bone metastases. Bryden AA; Islam S; Freemont AJ; Shanks JH; George NJ; Clarke NW Prostate Cancer Prostatic Dis; 2002; 5(1):59-62. PubMed ID: 15195132 [TBL] [Abstract][Full Text] [Related]
29. [Early generalisation of on occult prostatic adenocarcinoma]. Simoneau J; Gareau R Union Med Can; 1975 Jan; 104(1):110-4. PubMed ID: 1111191 [No Abstract] [Full Text] [Related]
30. Prostate carcinoma metastasis to the mandible: report of a case. Laski R; Ziccardi VB; Najjar T J N J Dent Assoc; 2002; 73(3):12-5, 36. PubMed ID: 12402528 [No Abstract] [Full Text] [Related]
31. High dose hook effect in serum total and free prostate specific antigen in a patient with metastatic prostate cancer. Furuya Y; Cho S; Ohta S; Sato N; Kotake T; Masai M J Urol; 2001 Jul; 166(1):213. PubMed ID: 11435864 [No Abstract] [Full Text] [Related]
32. Clinical debut of a prostatic cancer with metastasis in manubrium sterni. Rodríguez Collar TL; Matos Quesada D; Báez Sarria F Arch Esp Urol; 2013 Mar; 66(2):251-2. PubMed ID: 23589606 [No Abstract] [Full Text] [Related]
34. The alpha-receptor for platelet-derived growth factor as a target for antibody-mediated inhibition of skeletal metastases from prostate cancer cells. Russell MR; Jamieson WL; Dolloff NG; Fatatis A Oncogene; 2009 Jan; 28(3):412-21. PubMed ID: 18850002 [TBL] [Abstract][Full Text] [Related]
35. [A 65-years-old man with sternal lesion]. Fonseca Aizpuru EM; Nuño Mateo FJ; Menéndez Calderón MJ; Segui Riesco E An Med Interna; 2005 Mar; 22(3):152-3. PubMed ID: 15906465 [No Abstract] [Full Text] [Related]
36. [Role of biochemical indices as metastatic markers in patients with prostatic cancer invading skeleton]. Liubimova NV; Trapeznikova MF; Robins SP; Ognerubov SA; Kushlinskiĭ NE Urologiia; 2000; (4):15-9. PubMed ID: 11186686 [TBL] [Abstract][Full Text] [Related]
37. How and what kind of bone is made by metastatic cells of prostatic cancer. Franck JL; Bouteiller G; Fauchier C; Arlet J Med Hypotheses; 1982 Dec; 9(6):587-97. PubMed ID: 7167073 [TBL] [Abstract][Full Text] [Related]
38. Morphological studies on the bone tissue of sternum in osteomyelosclerosis, panmyelosis and chronic myeloleukosis. Velizarov A; Valkov I Nauchni Tr Vissh Med Inst Sofiia; 1970; 49(3):61-71. PubMed ID: 4253273 [No Abstract] [Full Text] [Related]